瑞芬太尼强化麻醉在眼台植入术中的应用
发布时间：2019-07-15 09:00
【摘要】：目的观察瑞芬太尼经静脉泵入强化麻醉在眼台植入术中镇痛效果,了解其有效性和可控性。方法选择择期行眼内容物剜除和眼台植入术患者40例,随机分为观察组和对照组各20例。2组患者先进性局部麻醉,观察组于手术开始前泵入瑞芬太尼达2μg/kg,观察记录2组手术前、手术开始,牵拉肌肉、植入眼台和手术结束时患者收缩压(SBP)、舒张压(DBP)、平均动脉压(MAP)、心率(HR)、视觉膜拟评分法(VAS)评分等指标及呼吸抑制、肌僵直等不良反应发生情况。结果 2组各时点SBP、DBP、MAP、HR指标均较术前有所波动,观察组波动程度低于对照组,差异有统计学意义(P0.05),观察组VAS评分明显低于对照组,差异有统计学意义(P0.05)。2组术中均未观察到呼吸肌僵直病例,观察组出现一过性呼吸抑制2例。结论瑞芬太尼经静脉泵入强化麻醉有效减轻眼台植入术中的牵拉反应,镇痛效果好,且对生理功能干扰小,不良反应小,值得临床推广应用。
[Abstract]:Objective to observe the analgesic effect of remifentanil intravenous infusion intensive anesthesia during orbital implantation and to understand its effectiveness and controllability. Methods 40 patients undergoing elective exhumation and orbital implantation were randomly divided into observation group (n = 20) and control group (n = 20). The patients in the two groups were anesthetized with advanced local anesthesia. The observation group was pumped with remifentanidas 2 渭 g / kg, before the operation, the muscle was pulled at the beginning of the operation, the systolic blood pressure (SBP),) diastolic blood pressure (DBP),) mean arterial pressure (MAP), heart rate (HR),) was recorded at the end of the operation and at the end of the operation. Visual membrane score (VAS) score and respiratory inhibition, muscle stiffness and other adverse reactions. Results the SBP,DBP,MAP,HR index of the two groups fluctuated at all time points, the fluctuation degree of the observation group was lower than that of the control group, the difference was statistically significant (P 0.05), the VAS score of the observation group was significantly lower than that of the control group, the difference was statistically significant (P 0.05). No cases of respiratory muscle rigidity were observed during operation in the two groups. There were 2 cases of transient respiratory suppression in the observation group. Conclusion remifentanil intravenous infusion of intensive anesthesia can effectively reduce the traction reaction during orbital implantation, the analgesic effect is good, and the interference to physiological function is small, and the adverse reactions are small, so it is worth popularizing and applying in clinic.
【作者单位】： 青海省湟中县第一人民医院麻醉科;
【分类号】：R614
，
本文编号：2514593
[Abstract]:Objective to observe the analgesic effect of remifentanil intravenous infusion intensive anesthesia during orbital implantation and to understand its effectiveness and controllability. Methods 40 patients undergoing elective exhumation and orbital implantation were randomly divided into observation group (n = 20) and control group (n = 20). The patients in the two groups were anesthetized with advanced local anesthesia. The observation group was pumped with remifentanidas 2 渭 g / kg, before the operation, the muscle was pulled at the beginning of the operation, the systolic blood pressure (SBP),) diastolic blood pressure (DBP),) mean arterial pressure (MAP), heart rate (HR),) was recorded at the end of the operation and at the end of the operation. Visual membrane score (VAS) score and respiratory inhibition, muscle stiffness and other adverse reactions. Results the SBP,DBP,MAP,HR index of the two groups fluctuated at all time points, the fluctuation degree of the observation group was lower than that of the control group, the difference was statistically significant (P 0.05), the VAS score of the observation group was significantly lower than that of the control group, the difference was statistically significant (P 0.05). No cases of respiratory muscle rigidity were observed during operation in the two groups. There were 2 cases of transient respiratory suppression in the observation group. Conclusion remifentanil intravenous infusion of intensive anesthesia can effectively reduce the traction reaction during orbital implantation, the analgesic effect is good, and the interference to physiological function is small, and the adverse reactions are small, so it is worth popularizing and applying in clinic.
【作者单位】： 青海省湟中县第一人民医院麻醉科;
【分类号】：R614
，
本文编号：2514593
本文链接：https://www.wllwen.com/yixuelunwen/mazuiyixuelunwen/2514593.html
最近更新
教材专著
